Literature DB >> 23917286

Black-white differences in breast cancer outcomes among older Medicare beneficiaries: does systemic treatment matter?

Jeanne S Mandelblatt, Vanessa B Sheppard, Alfred I Neugut.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23917286      PMCID： PMC4255459          DOI： 10.1001/jama.2013.8273

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.

Authors:  Caroline Lohrisch; Charles Paltiel; Karen Gelmon; Caroline Speers; Suzanne Taylor; Jeff Barnett; Ivo A Olivotto
Journal:  J Clin Oncol       Date:  2006-10-02       Impact factor: 44.544

2.  Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.

Authors:  Christopher R Friese; T May Pini; Yun Li; Paul H Abrahamse; John J Graff; Ann S Hamilton; Reshma Jagsi; Nancy K Janz; Sarah T Hawley; Steven J Katz; Jennifer J Griggs
Journal:  Breast Cancer Res Treat       Date:  2013-03-31       Impact factor: 4.872

3.  Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.

Authors:  Nicolien T van Ravesteyn; Clyde B Schechter; Aimee M Near; Eveline A M Heijnsdijk; Michael A Stoto; Gerrit Draisma; Harry J de Koning; Jeanne S Mandelblatt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-30       Impact factor: 4.254

4.  The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy.

Authors:  Alfred I Neugut; Grace Clarke Hillyer; Lawrence H Kushi; Lois Lamerato; S David Nathanson; Christine B Ambrosone; Dana H Bovbjerg; Jeanne S Mandelblatt; Carol Magai; Wei-Yann Tsai; Judith S Jacobson; Dawn L Hershman
Journal:  Breast J       Date:  2012-04-05       Impact factor: 2.431

5.  Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.

Authors:  Jennifer J Griggs; Eva Culakova; Melony E S Sorbero; Marek S Poniewierski; Debra A Wolff; Jeffrey Crawford; David C Dale; Gary H Lyman
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

6.  Characteristics associated with differences in survival among black and white women with breast cancer.

Authors:  Jeffrey H Silber; Paul R Rosenbaum; Amy S Clark; Bruce J Giantonio; Richard N Ross; Yun Teng; Min Wang; Bijan A Niknam; Justin M Ludwig; Wei Wang; Orit Even-Shoshan; Kevin R Fox
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

7.  Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.

Authors:  Dawn L Hershman; Joseph M Unger; William E Barlow; Laura F Hutchins; Silvana Martino; C Kent Osborne; Robert B Livingston; Kathy S Albain
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

8.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Authors:  C Davies; J Godwin; R Gray; M Clarke; D Cutter; S Darby; P McGale; H C Pan; C Taylor; Y C Wang; M Dowsett; J Ingle; R Peto
Journal:  Lancet       Date:  2011-07-28       Impact factor: 79.321

9.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

10.  Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.

Authors:  Yaojen Chang; Clyde B Schechter; Nicolien T van Ravesteyn; Aimee M Near; Eveline A M Heijnsdijk; Lucile Adams-Campbell; David Levy; Harry J de Koning; Jeanne S Mandelblatt
Journal:  Breast Cancer Res Treat       Date:  2012-10-27       Impact factor: 4.872
View more
  7 in total

1.  Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer Population.

Authors:  Geoffrey C Kabat; Mindy Ginsberg; Joseph A Sparano; Thomas E Rohan
Journal:  J Racial Ethn Health Disparities       Date:  2016-12-21

2.  Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.

Authors:  Alana Biggers; Yushu Shi; John Charlson; Elizabeth C Smith; Alicia J Smallwood; Ann B Nattinger; Purushottam W Laud; Joan M Neuner
Journal:  J Clin Oncol       Date:  2016-10-24       Impact factor: 44.544

Review 3.  Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010.

Authors:  Eileen B O'Keefe; Jeremy P Meltzer; Traci N Bethea
Journal:  Front Public Health       Date:  2015-04-15

4.  Focus on You: Cancer clinical trials perspectives.

Authors:  Brandi N Robinson; Antoinette F Newman; Sherrie F Wallington; Sandra M Swain
Journal:  Contemp Clin Trials Commun       Date:  2016-09-16

5.  Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study.

Authors:  Deirdre A Hill; Eric R Prossnitz; Melanie Royce; Andrea Nibbe
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

6.  Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity.

Authors:  Maura K McCall; Mary Connolly; Bethany Nugent; Yvette P Conley; Catherine M Bender; Margaret Q Rosenzweig
Journal:  J Cancer Educ       Date:  2020-06       Impact factor: 2.037

7.  Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium.

Authors:  Marilyn L Kwan; Esther M John; Bette J Caan; Valerie S Lee; Leslie Bernstein; Iona Cheng; Scarlett Lin Gomez; Brian E Henderson; Theresa H M Keegan; Allison W Kurian; Yani Lu; Kristine R Monroe; Janise M Roh; Salma Shariff-Marco; Richard Sposto; Cheryl Vigen; Anna H Wu
Journal:  Am J Epidemiol       Date:  2013-10-09       Impact factor: 5.363
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.